Document is current

Any future updates will be listed below

Repurposing of FDA-approved drugs as potential inhibitors of L1 β-lactamase in Stenotrophomonas maltophilia

Crossref DOI link: https://doi.org/10.1007/s11696-025-04046-z

Published Online: 2025-05-09

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark